Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 9/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | TLR4 | O00206 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Genipin SCHEMBL22557817 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL25807077 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL16697983 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL20083921 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL7478142 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL34249 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL9609096 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL13526030 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL5134206 | 0.99 | PTPN1 (0.69) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL19356583 | 0.97 | PTPN1 (0.71) | PTPN1MEN1KMT2ATLR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080286329-A1 | Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom | CARNEGIE MELLON UNIVERSITY (US) | 2008-11-20 | — | — | US | claimed |
| US-20080111272-A1 | METHOD AND APPARATUS FOR MANUFACTURING PLASMA BASED PLASTICS AND BIOPLASTICS PRODUCED THEREFROM | ALLEGHENY-SINGER RESEARCH INSTITUTE | 2008-05-15 | — | — | US | claimed |
| US-20250234857-A1 | VESSEL TREATMENT SYSTEMS, METHODS, AND KITS | THE GENERAL HOSPITAL CORPORATION | 2025-07-24 | — | — | US | disclosed |
| US-12357547-B2 | Compositions containing microcapsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-12291694-B2 | Dye scavenger and method of production of dye scavenger | Krusic, Melina Kalagasidis (RS) | 2025-05-06 | — | — | US | disclosed |
| US-12207648-B2 | Vessel treatment systems, methods, and kits | THE GENERAL HOSPITAL CORPORATION (US) | 2025-01-28 | — | — | US | disclosed |
| EP-3894531-B1 | DYE SCAVENGER AND METHOD OF PRODUCTION OF DYE SCAVENGER | KALAGASIDIS KRUSIC MELINA (RS) | 2024-06-19 | — | — | EP | disclosed |
| US-20230310300-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | HFC PRESTIGE SERVICE GERMINY GMBH (DE) | 2023-10-05 | — | — | US | disclosed |
| US-20230172820-A1 | Compositions Containing Microcapsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2023-06-08 | — | — | US | disclosed |
| EP-4171500-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | Wella Germany GmbH (DE) | 2023-05-03 | — | — | EP | disclosed |
| CN-115806633-A | Genipin-crosslinked PDRN-SACRAN biopolymer scaffold | 比贝婷作物科学有限公司 | 2023-03-17 | — | — | CN | disclosed |
| US-20220160752-A1 | GENIPIN-CROSSLINKED PDRN-SACRAN BIOPOLYMER SCAFFOLDS | PERPETUUM CROPSCIENCE BVBA (BE) | 2022-05-26 | — | — | US | disclosed |
| EP-3122444-B1 | PROCESS FOR MAKING MEMBRANES | APPLIED BIOMIMETIC AS (DK) | 2021-06-30 | — | — | EP | disclosed |
| US-9364503-B2 | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom | CARMELL THERAPEUTICS CORPORATION (US) | 2016-06-14 | — | — | US | disclosed |
| US-20150165093-A1 | Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom | ALLEGHENY-SINGER RESEARCH INSTITUTE | 2015-06-18 | — | — | US | disclosed |
| US-8911789-B2 | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom | CARNEGIE MELLON UNIVERSITY (US) | 2014-12-16 | — | — | US | disclosed |
| US-20130189370-A1 | Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom | CARNEGIE MELLON UNIVERSITY (US) | 2013-07-25 | — | — | US | disclosed |
| US-20130108671-A1 | HEMOSTATIC COMPOSITIONS | BAXTER HEALTHCARE S.A. (CH) | 2013-05-02 | — | — | US | disclosed |
| US-8293530-B2 | Method and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom | CARNEGIE MELLON UNIVERSITY (US) | 2012-10-23 | — | — | US | disclosed |
| US-20080111272-A1 | METHOD AND APPARATUS FOR MANUFACTURING PLASMA BASED PLASTICS AND BIOPLASTICS PRODUCED THEREFROM | ALLEGHENY-SINGER RESEARCH INSTITUTE | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12357547-B2 | Compositions containing microcapsules | COPE, SAAL1, AUP1 | PTPN1 2015/4885MEN1 2096/4885KMT2A 4219/4885 |
| US-20230310300-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | KRT18, MKI67, IK | PTPN1 1537/4885MEN1 811/4885KMT2A 876/4885 |
| US-20230172820-A1 | Compositions Containing Microcapsules | COPE, SAAL1, AUP1 | PTPN1 2015/4885MEN1 2096/4885KMT2A 4219/4885 |
| US-20220160752-A1 | GENIPIN-CROSSLINKED PDRN-SACRAN BIOPOLYMER SCAFFOLDS | PARN, GMNN, POLN | PTPN1 2724/4885MEN1 4497/4885KMT2A 4107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.